vs

Side-by-side financial comparison of OPTICAL CABLE CORP (OCC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $19.8M, roughly 1.9× OPTICAL CABLE CORP). On growth, OPTICAL CABLE CORP posted the faster year-over-year revenue change (1.8% vs -57.1%). Over the past eight quarters, OPTICAL CABLE CORP's revenue compounded faster (15.5% CAGR vs -46.5%).

Optical Cable Corporation, headquartered in Roanoke, Virginia, manufactures fiber optical cable. The company's cable is largely used for telecommunications and is sold both in the US and seventy other countries worldwide. OCC also manufactures military land tactical fiber optic cable for the U.S. military.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

OCC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.9× larger
ORGO
$37.2M
$19.8M
OCC
Growing faster (revenue YoY)
OCC
OCC
+58.8% gap
OCC
1.8%
-57.1%
ORGO
Faster 2-yr revenue CAGR
OCC
OCC
Annualised
OCC
15.5%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OCC
OCC
ORGO
ORGO
Revenue
$19.8M
$37.2M
Net Profit
$48.6K
Gross Margin
31.9%
30.8%
Operating Margin
1.4%
-185.1%
Net Margin
0.2%
Revenue YoY
1.8%
-57.1%
Net Profit YoY
-87.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCC
OCC
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$19.8M
$225.6M
Q3 25
$19.9M
$150.9M
Q2 25
$17.5M
$101.0M
Q1 25
$15.7M
$86.7M
Q4 24
$19.5M
$126.7M
Q3 24
$16.2M
$115.2M
Q2 24
$16.1M
$130.2M
Net Profit
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
$48.6K
$43.7M
Q3 25
$301.9K
$21.6M
Q2 25
$-697.9K
$-9.4M
Q1 25
$-1.1M
$-18.8M
Q4 24
$373.5K
$7.7M
Q3 24
$-1.6M
$12.3M
Q2 24
$-1.6M
$-17.0M
Gross Margin
OCC
OCC
ORGO
ORGO
Q1 26
30.8%
Q4 25
31.9%
Q3 25
31.7%
Q2 25
30.4%
Q1 25
29.4%
72.6%
Q4 24
33.5%
75.5%
Q3 24
24.2%
76.7%
Q2 24
25.1%
77.6%
Operating Margin
OCC
OCC
ORGO
ORGO
Q1 26
-185.1%
Q4 25
1.4%
28.1%
Q3 25
2.8%
13.7%
Q2 25
-2.4%
-12.5%
Q1 25
-5.4%
-30.9%
Q4 24
3.4%
8.1%
Q3 24
-8.2%
5.4%
Q2 24
-8.1%
-10.7%
Net Margin
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
0.2%
19.4%
Q3 25
1.5%
14.3%
Q2 25
-4.0%
-9.3%
Q1 25
-7.0%
-21.7%
Q4 24
1.9%
6.1%
Q3 24
-9.6%
10.7%
Q2 24
-9.9%
-13.1%
EPS (diluted)
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCC
OCC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$237.5K
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$16.5M
Total Assets
$40.1M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCC
OCC
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$237.5K
$93.7M
Q3 25
$421.4K
$63.7M
Q2 25
$894.3K
$73.1M
Q1 25
$128.3K
$110.0M
Q4 24
$244.2K
$135.6M
Q3 24
$796.7K
$94.3M
Q2 24
$1.1M
$89.9M
Total Debt
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
$16.5M
$300.1M
Q3 25
$18.2M
$255.1M
Q2 25
$19.1M
$233.2M
Q1 25
$19.7M
$242.9M
Q4 24
$20.8M
$262.9M
Q3 24
$20.4M
$278.5M
Q2 24
$21.8M
$263.5M
Total Assets
OCC
OCC
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$40.1M
$598.7M
Q3 25
$40.2M
$509.8M
Q2 25
$39.1M
$461.1M
Q1 25
$37.8M
$467.4M
Q4 24
$40.4M
$497.9M
Q3 24
$37.6M
$446.3M
Q2 24
$39.9M
$443.2M
Debt / Equity
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCC
OCC
ORGO
ORGO
Operating Cash FlowLast quarter
$797.3K
Free Cash FlowOCF − Capex
$718.8K
FCF MarginFCF / Revenue
3.6%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
16.40×
TTM Free Cash FlowTrailing 4 quarters
$1.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
$797.3K
$39.4M
Q3 25
$-2.2M
$3.1M
Q2 25
$141.4K
$-32.9M
Q1 25
$2.7M
$-19.9M
Q4 24
$-1.5M
$10.9M
Q3 24
$552.4K
$8.7M
Q2 24
$373.7K
$4.7M
Free Cash Flow
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
$718.8K
$34.8M
Q3 25
$-2.3M
$844.0K
Q2 25
$73.4K
$-36.5M
Q1 25
$2.6M
$-23.6M
Q4 24
$-1.6M
$7.6M
Q3 24
$475.2K
$6.1M
Q2 24
$218.2K
$2.9M
FCF Margin
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
3.6%
15.4%
Q3 25
-11.4%
0.6%
Q2 25
0.4%
-36.1%
Q1 25
16.5%
-27.2%
Q4 24
-8.1%
6.0%
Q3 24
2.9%
5.3%
Q2 24
1.4%
2.2%
Capex Intensity
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
0.4%
2.1%
Q3 25
0.4%
1.5%
Q2 25
0.4%
3.6%
Q1 25
0.5%
4.2%
Q4 24
0.3%
2.7%
Q3 24
0.5%
2.2%
Q2 24
1.0%
1.4%
Cash Conversion
OCC
OCC
ORGO
ORGO
Q1 26
Q4 25
16.40×
0.90×
Q3 25
-7.29×
0.14×
Q2 25
Q1 25
Q4 24
-4.08×
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons